Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -211.76% is 28% below its 5-year average of -166.01%, around the middle of its 5-year range (-560.48%–-44.16%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.03% below its 12-month average of -209.59%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -211.76%.
RETURN ON EQUITY (ROE)
-211.76%
RETURN ON EQUITY (ROE) AVG TTM
-209.59%
RETURN ON EQUITY (ROE) AVG 3Y
-173.75%
RETURN ON EQUITY (ROE) AVG 5Y
-166.01%
RETURN ON EQUITY (ROE) AVG 10Y
-186.22%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-1.03%
CURRENT VS 3Y AVG
-21.87%
CURRENT VS 5Y AVG
-27.56%
CURRENT VS 10Y AVG
-13.71%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.09%
median of 641 covered companies
CURRENT VS SECTOR MEDIAN
-428.20%
vs the sector median at left
MetaVia Inc.
Market Cap
$9.62M
Return on Equity (ROE)
-211.76%
TTM Avg
-209.59%
3Y Avg
-173.75%
5Y Avg
-166.01%
Market Cap
$9.66M
Return on Equity (ROE)
-189.76%
TTM Avg
-774.75%
3Y Avg
-460.85%
5Y Avg
-442.56%
Market Cap
$9.72M
Return on Equity (ROE)
-440.15%
TTM Avg
-145.56%
3Y Avg
-96.97%
5Y Avg
-42.16%
Market Cap
$9.33M
Return on Equity (ROE)
-7.36%
TTM Avg
-85.10%
3Y Avg
-73.72%
5Y Avg
-96.61%
Market Cap
$9.92M
Return on Equity (ROE)
-252.37%
TTM Avg
-195.20%
3Y Avg
-116.68%
5Y Avg
-90.09%
Market Cap
$9.22M
Return on Equity (ROE)
-317.20%
TTM Avg
510.39%
3Y Avg
317.15%
5Y Avg
239.40%
Market Cap
$9.18M
Return on Equity (ROE)
-2248.48%
TTM Avg
-970.82%
3Y Avg
-532.13%
5Y Avg
-347.08%
Market Cap
$10.06M
Return on Equity (ROE)
N/A
TTM Avg
18596.99%
3Y Avg
9182.42%
5Y Avg
7349.85%
Market Cap
$10.45M
Return on Equity (ROE)
-57.34%
TTM Avg
-65.47%
3Y Avg
-124.96%
5Y Avg
28.05%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MetaVia Inc. (MTVA) | $9.62M | -211.76% | -209.59% | -173.75% | -166.01% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.66M | -189.76% | -774.75% | -460.85% | -442.56% |
| Ainos, Inc. (AIMD)vs › | $9.72M | -440.15% | -145.56% | -96.97% | -42.16% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.33M | -7.36% | -85.10% | -73.72% | -96.61% |
| Lifeward Ltd. (LFWD)vs › | $9.92M | -252.37% | -195.20% | -116.68% | -90.09% |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.22M | -317.20% | 510.39% | 317.15% | 239.40% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.18M | -2248.48% | -970.82% | -532.13% | -347.08% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | N/A | 18596.99% | 9182.42% | 7349.85% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.45M | -57.34% | -65.47% | -124.96% | 28.05% |
| Polyrizon Ltd. (PLRZ)vs › | $10.47M | N/A | -22.56% | -244.57% | 3710.91% |
ROE
-211.8%
ROA
-108.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -211.76% |
| 2026-03-31 | -144.66% |
| 2025-12-31 | -243.26% |
| 2025-09-30 | -256.14% |
| 2025-06-30 | -192.13% |
| 2025-03-31 | -560.48% |
| 2024-12-31 | -347.90% |
| 2024-09-30 | -214.10% |
| 2024-06-30 | -136.73% |
| 2024-03-31 | -164.55% |
| 2023-12-31 | -74.74% |
| 2023-09-30 | -54.90% |
| 2023-06-30 | -44.16% |
| 2023-03-31 | -66.78% |
| 2022-12-31 | -64.22% |
| 2022-09-30 | -233.56% |
| 2022-06-30 | -160.95% |
| 2022-03-31 | -124.37% |
| 2021-12-31 | -104.71% |
| 2021-09-30 | -493.32% |
| 2021-06-30 | -314.51% |
| 2021-03-31 | -214.98% |
| 2020-12-31 | -412.02% |
| 2020-09-30 | -224.37% |
| 2020-06-30 | -177.47% |
| 2020-03-31 | -276.65% |
| 2019-12-31 | -155.77% |
| 2019-06-30 | -717.92% |
| 2019-03-31 | -424.58% |
| 2018-09-30 | -246.26% |
| 2018-06-30 | -194.84% |
| 2018-03-31 | -159.21% |
| 2017-12-31 | -847.88% |
| 2017-09-30 | -340.57% |
| 2017-06-30 | -164.07% |
| 2017-03-31 | -78.98% |
| 2016-12-31 | -70.70% |
| 2016-09-30 | -36.84% |
